This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

In one of the most far-reaching changes to Pakistan's higher education admission system in recent years, Higher Education Commission Pakistan has centralised the MPhil and PhD admission process by ...

The much-anticipated Rotana Ras Al Khaimah – The Mangroves is on track to open its doors soon, marking a significant addition to the emirate's hospitality offerings. Situated within Ras Al Khaimah’s ...

LONDON, May 13 (Reuters) - Libya aims to restart its 220,000 barrel-per-day Ras Lanuf oil refinery within six to 12 months ‌to supply the domestic market, National Oil Corporation (NOC) chairman ...

Fugitive driver tracked and caught after late-night crash in Al Jazeera Al Hamra Ras Al Khaimah Police arrested an Asian driver within five hours after he fled the scene of a traffic accident ...

To say there was a crowded field in the race for Newark mayor was putting it mildly. But in the end, it didn't matter. The Associated Press projects incumbent Ras Baraka, a progressive Democrat, will ...

Grieving father calls for fencing after son dies in Wadi Al Aeem tragedy 16-year-old Emirati boy drowned in a dam in Ras Al Khaimah’s Wadi Athen in Al Aeem area family Ras Al Khaimah: A 16-year-old ...

Planet's Tanager-1 satellite observed this methane plume in Midland, Texas, in May 2025. Credit: Planet and Carbon Mapper SAN FRANCISCO – Planet is developing a new version of its Tanager spacecraft ...

The 2026 NFL draft has officially come and gone, and now it's time for the post-draft over-analysis period to begin. The Tennessee Titans came away with an impressive eight-player draft class with ...

RAS -- also known as Relative Athletic Score -- is a measurement of a player's athletic testing in relation to both size and historic results. Each individual measurement is graded on a scale of 0-10 ...

Earlier this week, Revolution Medicines reported positive results from a global Phase III trial of its RAS‑targeting inhibitor daraxonrasib (RMC-6236) in metastatic pancreatic ductal adenocarcinoma ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.